Loading candles…
Valiant Laboratories Ltd, originally established in 1980 as a partnership firm named M/s. Bharat Chemicals, converted into a public limited company in August 2021. The company operates in the pharmaceuticals and speciality chemicals industries, focusing on manufacturing Active Pharmaceutical Ingredients (APIs), particularly Paracetamol. It is recognized as a critical supplier of ingredients used in analgesic and antipyretic medications. Based in India, Valiant Laboratories functions as part of the broader Aarti Group ecosystem, leveraging longstanding industry relationships and manufacturing expertise. Its business segments include pharmaceuticals and speciality chemicals, with no publicly listed shares or subsidiaries reported.
This page is a live market overview for VALIANT LABORATORIES LTD (VALIANTLAB) on the NSE. As a listed security, VALIANT LABORATORIES LTD is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for VALIANTLAB before placing trades on tick2trade.
As of the latest feed, VALIANTLAB last traded at ₹126.56 on NSE, up ₹0 (0.00%) from the previous close of ₹126.56. Today's session range is ₹0 – ₹0, against a 52-week band of ₹49.51 – ₹132.25. Traded volume today stands at 65.19K shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for VALIANTLAB in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether VALIANTLAB is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for VALIANT LABORATORIES LTD before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in VALIANTLAB. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated VALIANTLAB option chain page linked from this overview.
| Results - FY26 | To consider and approve the financial results for the period ended Jun 30, 2026 | 10 Aug 2026 |
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026 | 14 May 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 | 11 Feb 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended September 30, 2025 | 11 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 | 8 Aug 2025 |
| Fund Raising | To consider Fund Raising | 9 Jul 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 and other business matters | 20 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.